Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter.

doi:10.1007/s12022-021-09698-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter.

Endocrine pathology - 1 Dec 2022

Repaci Andrea, Salituro Nicola, Vicennati Valentina, Monari Fabio, Cavicchi Ottavio, de Biase Dario, Ciarrocchi Alessia, Acquaviva Giorgia, De Leo Antonio, Gruppioni Elisa, Pagotto Uberto, Tallini Giovanni

Abstract excerpt

Follicular thyroid carcinoma (FTC) represents the second most common malignant thyroid neoplasm after papillary carcinoma (PTC). FTC is characterized by the tendency to metastasize to distant sites such as bone and lung. In the last 20 years, the understanding of the molecular pathology of thyroid tumors has greatly improved. Uncommon BRAF non-V600E mutations have been identified and are generally believed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Bone Neoplasms
Share to Goiter

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Open in PubMed

Identifiers

PMID: 34843063
DOI: 10.1007/s12022-021-09698-7

Provenance

PubMed metadata and Literature Corpus relationships.